CREATIVE IRREVOCABLE LICENSE AGREEMENTIrrevocable License Agreement • March 13th, 2000 • Creative Biomolecules Inc • Biological products, (no disgnostic substances) • Delaware
EX-10.3 4 dex103.htm IRREVOCABLE LICENSE AGREEMENT IRREVOCABLE LICENSE AGREEMENT THIS IRREVOCABLE LICENSE AGREEMENT (this “Agreement”), made as of the 11th day of April 2011,Irrevocable License Agreement • May 5th, 2020 • New Jersey
By and Between: Bedminster 2 Funding, LLC, having an address c/o Advance Realty, 1430 Route 206, Suite 100, Bedminster, NJ 07921 (hereinafter designated as the “Licensor”);
ContractIrrevocable License Agreement • August 20th, 2014
irrevocable license to reproduce, pub- lish or otherwise use, and to authorize others to use, for Federal Government purposes:
FOURTH AMENDMENT TO IRREVOCABLE LICENSE AGREEMENTIrrevocable License Agreement • February 28th, 2013 • Amarin Corp Plc\uk • Pharmaceutical preparations
WHEREAS, Licensor and Licensee entered into a License Agreement dated April 11, 2011 for an agreed upon 3,303 square feet of office space located at 1420 Route 206, Bedminster, NJ (the “1420 Premises”); a First Amendment dated May 11, 2011 which relocated Licensee to Suite # 200 consisting of an agreed-upon 9,747 square feet of office space located in 1430 Route 206, Bedminster, NJ (the “1430 Premises”); a Second Amendment dated April 25, 2012 and a Third Amendment dated July 17, 2012 (collectively, the “License”); and
IRREVOCABLE LICENSE AGREEMENTIrrevocable License Agreement • April 24th, 2012 • California
THIS IRREVOCABLE LICENSE AGREEMENT, subject to termination as set forth hereinbelow (“Agreement”) is entered into as of the day of , 2012 by and between CP III T&C SUNNYVALE, LLC, a Delaware limited liability company (“Carmel”), and the CITY OF SUNNYVALE, a California municipal corporation, as Successor Agency to the Redevelopment Agency of the City of Sunnyvale (the “City”).
SECOND AMENDMENT TO IRREVOCABLE LICENSE AGREEMENTIrrevocable License Agreement • August 8th, 2012 • Amarin Corp Plc\uk • Pharmaceutical preparations
WHEREAS, Licensor and Licensee entered into a License Agreement dated April 11, 2011 for an agreed upon 3,303 square feet of office space located at 1420 Route 206, Bedminster, NJ (the “1420 Premises”); and a First Amendment dated May 11, 2011 which relocated Licensee to Suite # 200 consisting of an agreed-upon 9,747 square feet of office space located in 1430 Route 206, Bedminster, NJ (the “1430 Premises”); and
THIRD AMENDMENT TO IRREVOCABLE LICENSE AGREEMENTIrrevocable License Agreement • August 8th, 2012 • Amarin Corp Plc\uk • Pharmaceutical preparations
WHEREAS, Licensor and Licensee entered into a License Agreement dated April 11, 2011 for an agreed upon 3,303 square feet of office space located at 1420 Route 206, Bedminster, NJ (the “1420 Premises”); a First Amendment dated May 11, 2011 which relocated Licensee to Suite # 200 consisting of an agreed-upon 9,747 square feet of office space located in 1430 Route 206, Bedminster, NJ (the “1430 Premises”) and Second Amendment dated April 25, 2012; and
